作者: SOMADA, Atsushi ; HARASAKI, Tamako ; UCHIDA, Takuya ; YASUDA, Hiroshi ; KONOSU, Toshiyuki ; FUKUOKA, Takashi ; MORI, Makoto ; NAKAMURA, Yoshie ; SEKI, Shinobu ; NAKAGAWA, Akihiko ; INOUE, Shin-ichi ; KAMAI, Yasuki ; OIDA, Sadao ; HARADA, Yoshiko ; SETA, Yasuo ; OHYA, Satoshi ; SHIBAYAMA, Takahiro

Synthesis and in vitro antifungal activities of a novel triazole antifungal agent CS-758 (former name, R-120758) are described. The minimum inhibitory concentrations (MICs) of a series of dioxane-triazole compounds related to R-102557 were examined. Variation of the length of the chain between the dioxane ring and the phenyl ring revealed that the linkage with two double bonds is the most preferable. When a cyano group was introduced to the C4 position on the benzene ring, MICs improved further. A fluorine atom was introduced to obtain CS-758. The MICs of CS-758 surpassed those of fluconazole and itraconazole against Candida, Aspergillus and Cryptococcus species. The precursor (E,E)-aldehyde was synthesized stereoselectively from 3-fluoro-4-methylbenzonitrile using the Horner-Wadsworth-Emmons reaction.

2000-01-01·Chemical and Pharmaceutical Bulletin4区 · 医学

Synthesis and Antifungal Activities of R-102557 and Related Dioxane-Triazole Derivatives.

4区 · 医学

Article

作者: Yasuda, Hiroshi ; Kamai, Yasuki ; Oida, Sadao ; Tajima, Yawara ; Habuki, Shinobu ; Fukuoka, Takashi ; Konosu, Toshiyuki ; Somada, Atsushi ; Tanaka, Teruo ; Harasaki, Tamako ; Ohya, Satoshi ; Nakamura, Yoshie

Novel triazole compounds with a dioxane ring were synthesized. Condensation of the diol precursor 10 with various aromatic aldehydes 11-13 under acidic conditions afforded a series of dioxane-triazole compounds 14-16. The antifungal activities of the compounds 14-16 were evaluated in vivo in mice infection models against Candida and Aspergillus species. High activities were seen for the derivatives with one or two double bond(s) and an aromatic ring substituted with an electron-withdrawing group in the side chain. Among the derivatives, R-102557 (16R: Ar=4-(2,2,3,3-tetrafluoropropoxy)phenyl) showed excellent in vivo activities against Candida, Aspergillus and Cryptococcus species. It also showed high tolerance in a preliminary toxicity study in rats.

100 项与 R-102557 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
曲霉菌病	药物发现	日本	Sankyo Co., Ltd. (Tokyo)	-
念珠菌病	药物发现	日本	Sankyo Co., Ltd. (Tokyo)	-
隐球菌病	药物发现	日本	Sankyo Co., Ltd. (Tokyo)	-